top of page
My Post - 2021-07-08T181150.838.png

Geniebiome collaborates with CUHK on clinical trial to study the impact of a microbiome immunity for

Updated: May 4, 2022


Study aims to evaluate in elderlies and patients with type 2 diabetes, the impact of G-NiiB Immunity Pro (SIM02) in reduction of vaccine-related adverse reactions and improvement of COVID-19 vaccine efficacy

29 views0 comments
bottom of page